Skip to main content
. 2016 May 13;31(2):311–319. doi: 10.3803/EnM.2016.31.2.311

Table 1. Baseline Characteristics of Study Subjects.

Variable Metabolic syndrome Overall (n=13,496)
No (n=11,832) Yes (n=1,664) P value
Male sex 6,852 (58) 1,316 (79) <0.001 8,168 (61)
Age, yr 50.5±6.6 52.3±6.5 <0.001 50.7±6.6
Smoking, current/former/never, % 17/29/54 27/37/36 <0.001 19/30/51
BMI, kg/m2 23.4±2.6 26.5±2.4 <0.001 23.8±2.7
 Overweight (25≤BMI<30) 2,784 (24) 1,258 (76) <0.001 4,042 (30)
 Obesity (BMI≥30) 134 (1) 109 (7) <0.001 243 (2)
Body fat, % 23.3±6.1 25.7±5.7 0.004 23.6±6.1
 Male 20.2±4.4 23.8±4.1 <0.001 20.8±4.5
 Female 27.7±5.4 33.1±4.9 <0.001 28.0±5.5
Abdominal fat, % 0.88±0.06 0.93±0.06 <0.001 0.88±0.06
 Male 0.89±0.06 0.93±0.05 <0.001 0.90±0.06
 Female 0.85±0.06 0.91±0.06 <0.001 0.86±0.06
Systolic BP, mm Hg 109.9±14.2 121.0±15.3 <0.001 111.3±14.8
Diastolic BP, mm Hg 67.7±9.8 74.4±10.0 <0.001 68.5±10.0
Total cholesterol, mg/dL 188.0±30.7 191.9±33.2 <0.001 188.5±31.0
LDL-C, mg/dL 122.8±27.9 125.4±29.9 0.001 123.1±28.2
HDL-C, mg/dL 59.4±13.5 47.3±10.9 <0.001 57.9±13.8
 Male 55.5±11.9 47.2±11.3 <0.001 54.2±12.2
 Female 64.8±13.8 47.7±9.2 <0.001 63.6±14.2
Triglycerides, mg/dL 114.7±63.9 214.0±102.5 <0.001 126.9±77.1
Fasting glucose, mg/dL 87.5±12.9 103.7±23.8 <0.001 89.5±15.6
HbA1c, % 5.3±0.5 5.9±0.9 <0.001 5.4±0.6
HOMA-IR 1.9±0.9 2.9±1.5 <0.001 2.1±1.1
TSH, mU/L 2.4±1.3 2.3±1.3 0.017 2.3±1.3
T3, nmol/L 1.72±0.28 1.78±0.29 <0.001 1.72±0.28
T4, nmol/L 108.6±17.9 108.3±18.4 0.521 108.6±17.9
T3-to-T4 ratio 0.016±0.003 0.017±0.003 <0.001 0.016±0.003

Values are expressed as number (%) or mean±SD. Demographic and biochemical characteristics of the study population with respect to the development of metabolic syndrome were compared using an independent t test for continuous variables and chi-square test for categorical variables.

BMI, body mass index; BP, blood pressure; LDL-C, low density lipoprotein cholesterol; HDL-C, high density lipoprotein cholesterol; HbA1c, glycated hemoglobin; HOMA-IR, homeostasis model assessment of insulin resistance; TSH, thyroid stimulating hormone; T3, triiodothyronine; T4, thyroxine.